Katelin Haynes, Queensland Program Manager ASHM

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Katelin Haynes

Katelin Haynes

As the Queensland Program Manager, Katelin works across the major program areas of HIV, viral hepatitis and sexual health. Katelin has recently completed her PhD in medical research.

Interested health sector parties in Queensland (including clinicians, Aboriginal and Islander Community-controlled Health Services, community and sexual health workers and organisations) can contact Katelin about any of ASHM’s Queensland activities including:



  • Deadly Sex Congress for Aboriginal and Torres Strait Islander health workers

  • HIV, viral hepatitis, sexual health and harm reduction workforce development program

  • ASHM Membership enquiries including specific benefits and scholarships for Queensland members

  • HTLV-1 Program


 


 

Posted by on in Uncategorised Posts

Australasian Viral Hepatitis Conference: Cross Track Session - Viral Hepatitides

Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL) spoke on hepatitis A in Australia. Hepatitis A is the most common hepatitis worldwide. Scott provided a good summary of the hepatitis A virus structure and worldwide prevalence. He then went on to relate the three largest outbreaks of hepatitis A in Australia, including the most recent involving frozen mixed berries imported from China.

 

Kathy Jackson, Senior Scientist, also of VIDRL, spoke on the hepatitis delta virus (HDV) in Australia. HDV is the least common form of viral hepatitis but leads to the most severe liver disease. HDV is a "satellite virus" which can only exist in the presence of the hepatitis B virus. There are currently no national testing or treatment guidelines for HDV. VIDRL recommends testing first anti-HDV, and if positive followed by a HDV PCR, and then viral load (if required for treatment monitoring.

 

Dr David Siebert, Infectious Diseases physician and microbiologist at the Princess Alexandra Hospital in Brisbane gave an update on the hepatitis E virus in Australia. Hepatitis E is an emerging infectious disease in industrialised countries and is not simply a travel associated infection. Hepatitis E virus should be considered when a patient under immune suppression presents with acute hepatitis. Currently there is no screening of blood products for hepatitis E, making the transmission of hepatitis E through transfusion inevitable in Australia.

Tagged in: INHSU2016

With just over two weeks until the virtual 2020 Joint Australasian HIV&AIDS and Sexual Health Conferences, now is a… https://t.co/qdLZhBZgQ7

ASHM ASHM